Skip to main content
Explore URMC

URMC Logo

menu
URMC / Giving / Medical School for an Evening

Medical School for an Evening - New Frontiers in Surgery

Date: Thursday, June 15th  

Time: 5:30pm – 8:00pm

Location: Larry and Cindy Bloch Alumni and Advancement Center, 300 East River Road, Rochester, NY 14627

Parking: Bloch Alumni and Advancement Center

RSVP by Wednesday, June 7th to Caitlyn Conway (585) 275-3591

Event Title: New Frontiers in Surgery

register here

Program Outline:

5:30pm Reception
6:00pm

Remarks

Mark B. Taubman, MD

6:15pm

Session 1, Cut Twice, Operate Once – An Innovative Approach for Safer Surgery

Presenters:

  • Ahmed E. Ghazi, MD, FEBU
  • Jonathan Stone, MD, MSE
7:00pm Break
7:15pm

Session 2, A Perfect Match: Innovative Liver Regeneration and the Future of Liver Transplantation

Presenter:

  • Roberto Hernandez-Alejandro, MD, Chief, Division of Transplantation; Professor of Surgery
8:00pm Event Concludes

 

Presentation Description: 

Mark B. Taubman, MD

Mark B. Taubman, MD

CEO, University of Rochester Medical Center and UR Medicine
Dean, School of Medicine and Dentistry
Senior Vice President for Health Sciences

Dr. Taubman is CEO of the Medical Center, Dean of the School of Medicine and Dentistry, and Senior Vice President for Health Sciences at the University of Rochester.  He received his M.D. degree from New York University and completed his training in medicine and cardiology at the Brigham and Women’s Hospital and Harvard Medical School.  He has served on the faculties of Mt. Sinai School of Medicine in New York, Children’s Hospital Medical Center and Harvard Medical School in Boston, Massachusetts.  Dr. Taubman was previously the Charles E. Dewey Professor and Chairman of Medicine (2007-2010) and Chief of the Cardiology Division (2003-2009) at the University of Rochester.  In addition he was Director of the Aab Cardiovascular Research Institute (2005-2007) and Director of the Center for Cellular and Molecular Cardiology (2003-2005).  Dr. Taubman is a member of the American Heart Association, the American Society of Hypertension, the Association of University Cardiologists, and the Association of American Medical Colleges. He is a Fellow, American College of Cardiology and Fellow, American College of Physicians.  He is the former Editor-in-Chief, Arteriosclerosis, Thrombosis, and Vascular Biology. 

Dr. Taubman is an international authority in vascular biology with research interests in tissue factor biology and chemokines.  He has published widely – more than 120 articles, chapters, and books.

 

1.	Ahmed E. Ghazi, MD, FEBU (Jennifer)Ahmed E. Ghazi, MD, FEBU

Assistant Professor, Department of Urology; Director of Simulation Training and Education

Prior to joining the Urology faculty at the University of Rochester Dr. Ghazi had trained in three different continents and 4 countries.  He received his MD degree from Cairo University in Egypt in 2000, where he also completed his surgery training and Urology residency 2001-2005. After which he started a series of worldwide fellowships in state of the art minimal invasive Urological surgery. He completed a laparoscopic fellowship in Paris, France in 2008 under the supervision of Professor Claude Abbou MD (one of the modern founders and prominent laparoscopic surgeons, who revolutionized the laparoscopic technique for extraperitoneal laparoscopic radical prostatectomy for treatment of prostate cancer). He then completed a second laparoscopic fellowship in Austria in 2009 under the supervision of Professor Gunter Janetschek MD who specialized in the laparoscopic approach for selective removal of kidney tumors, leaving the remaining kidney intact and functioning. During his stay in Europe he received the European Board of Urology. He then moved to the United States where he completed a 2-year fellowship in the robotic treatment of various urologic cancers, prior to joining the staff at the Urology department, University of Rochester in 2012. Dr. Ghazi specializes in the diagnosis and minimal invasive treatment of cancers of the prostate, bladder, and kidney as well as minimal invasive treatment of complex stones of the urinary tract.

Since joining faculty, Dr. Ghazi had an interest in innovation, simulation and surgical training.  In 2012 he was awarded the George W. Corner Deans Teaching Fellowship (2013-2015) with the University of Rochester School of Medicine for development of an evidence-based, minimally invasive surgery-training curriculum. The following year he completed the prestigious Harvard Macy Institute program for Educators in Health Professions. He is currently enrolled in a Masters in Health Professions Education program at the Warner School of Education, University of Rochester.

In 2013 he established Sim-CAST (Simulation Center for Advanced Surgical Training), a 250 square-foot simulation training center at the Department of Urology that houses various state of the art surgical simulators including: a state of the art virtual reality (VR) DaVinci surgical skills simulator (DVSSS) (Intuitive Surgical, Sunnyvale, CA), a new Laparosocpic trainer and a fully equipped endoscopic tower (OLYMPUS, USA) with a 20 inch monitor, cautery generator, light source and endoscopic camera and various endoscopes.   In 2014, he partnered with Dr. Jonathan stone to develop innovative techniques for design and manufacturing of realistic, bleeding models using 3-D printing and polymer technology. The laboratory was named CAPS (Center for Advanced Personalized Simulation) following development of a patented technique to manufacture personalized models based on the patients imaging that are currently used for the novel concept for surgeons to practice and rehearsal the procedure prior to the scheduled surgery. Dr. Ghazi believes in a reciprocal relationship between innovation, research & education, where each informs & strengthens the others. He strives to produce translational academically research that is theoretically interesting, practical and with a direct patient benefit.  

 

Jonathan Stone, MD, MSE Jonathan Stone, MD, MSE

Chief Resident, Department of Neurosurgery; Director, Engineering and Technology Development

 Jonathan Stone is a resident in neurosurgery at the School of Medicine and Dentistry. Prior to earning an MS in biomedical engineering from the Hajim School of Engineering and Applied Sciences in 2016, he completed his undergraduate studies at Drew University and earned an MD from the University at Buffalo School of Medicine. After his residency, Stone will enter a peripheral nerve surgery fellowship at the Mayo Clinic in Rochester, Minnesota. He is looking forward to not only treating nerve injuries and malignancy, but also restoring nerve function and improving patients’ quality of life.

 

 

 

Roberto Hernandez-Alejandro, MDRoberto Hernandez-Alejandro, MD

Chief, Division of Transplantaation; Professor of Surgey

Dr. Roberto Hernandez-Alejandro has been the Chief of the Division of Transplantation at the University of Rochester and Professor of Surgery since August 2016, and was formerly the Director of Liver Transplantation at Western University, Canada. Subsequently, he received further training in live donor liver transplantation (LDLT) at the Kyoto University in Japan in 2009. Dr. Hernandez-Alejandro has published more than 60 peer reviewed publications in the area of HPB and liver transplantation and is frequently invited by national and international academic centers to give guest lectures.

In addition to his transplant work, Dr. Hernandez-Alejandro is heavily focused on liver resections for malignancies, and is one of only a handful of surgeons in the United States actively performing the ALPPS procedure (Associating Liver Partition and Portal vein Ligation for Staged hepatectomy). This surgical technique, which permits resection of advanced tumors by making use of the liver’s regenerative capacity, is now offered to patients with multiple liver metastases and in some instances, primary tumors of the liver.

With ALPPS, patients who were considered to have unresectable cancer with extensive tumor burden in the liver are now able to undergo surgery in this two staged approach. ALPPS not only improves their rate of survival, it also improves the quality of life, and in some cases patients may be cured. Dr. Hernandez-Alejandro has performed over 40 ALPPS procedures, thus far with 0% perioperative mortality. The three-year patient survival rate is currently 53% for patients who underwent the procedure compared with 0% for patients who underwent chemotherapy alone.

register here